ArticleVaccines2022

Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy.

Alborz Rahmani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.